Work

The role of ETV4 in Prostate Cancer

Year: 2013
Type: dissertation
Abstract: Prostate cancer is the second leading cause of deaths in the male population.An important advance in understanding the molecular basis of prostate cancer has been the discovery of translocations that involve one of the genes of the ETS family (ERG, ETV1, ETV4, ETV5, FLI1).Each one of these translocations results in deregulated expression of one of the ETS proteins, expression that is likely to play a direct role in prostate cancer pathogenesis.The role of ERG and ETV1 has been thoroughly investigated.This project has focused on the investigation of the mechanism whereby over-expression of the ETV4 gene mediates oncogenesis in the prostate.We have show that ETV4 inhibition by siRNA in the PC3 and DU145 cancer cell lines reduces cell proliferation, cell cycle progression, anchorage-independent growth in soft agar, tumor growth in a xenograft model.In addition, ETV4 inhibition reduces cell mobility and invasiveness only in the PC3 cells.Conversely, upon ETV4 over-expression in the nonmalignant cell line RWPE we have observed increased anchorage-independent growth, cell mobility and cell proliferation, which is probably mediated by down-regulation of p21, producing accelerated progression through the cell cycle.In addition, we have observed that ETV4 over-expression induces a set of morphological changes associated with changes in the expression pattern of epithelial (E-cadherin) and mesenchymal (N-cadherin and vimentin) markers: these changes are characteristic of the so-called epithelial to mesenchymal transition (EMT).In RWPE cells over-expressing ETV4 we have shown that the EMT may result from the increased expression of EMT-specific transcription factors such as Twist1, Slug1, Zeb1 and Zeb2.These results indicate that ETV4, as other ETS proteins (ERG, ETV5 and ETV1), plays a major role in invasiveness and cell migration.In addition, it emerges as unique in that it increases at the same time also the rate of proliferation of prostate cancer cells.To investigate in vivo the effects of ETV4 expression in prostate we have developed a mouse model: FVB mice in which the truncated form of ETV4, present in patients with TMPRSS2-ETV4 translocation, is expressed under the control of a modified rat probasin promoter that drives high levels of expression only in the prostate (ETV4-FVB mice).ETV4-FVB mice and control wild-type mice have been followed-up and studied by standard H&E staining.No prostate lesions have been found in any of the 6 months old mice, whereas prostatic intraepithelial neoplasia (PIN) lesions have been found in 57% of 10 months old ETV4-FVB mice (n=10) and in none of control mice.Pten loss is one of most common additional genetic alteration found in prostate cancer.Thus, V we have investigated the possible effect of the interaction of ETV4 expression with Pten loss by crossing our prostate-specific FVB-ETV4 mice with C57 black PTEN+/-mice: Pten+/-|ETV4 mice.In 7 months old animals we have observed neither prostatic hyperplasia nor PIN in wild type controls and FVB-ETV4 mice, PIN lesion in 33% of Pten +/-mice (n=3), and multifocal PIN lesions in all Pten+/-|ETV4 mice (n=9).These transgenic mice models suggest that ETV4 over-expression is sufficient to initiate neoplastic transformation and cooperates with Pten loss in promoting prostate cancer progression.The work performed during project has proven that ETV4 induces, both in vitro and in vivo, most and perhaps all of the features that make a tumor aggressive.In addition, we have generated an mouse model of prostate cancer that will provide further insight ETV4 in biology of prostate cancer and that might be useful to test the effectiveness of new therapeutic approaches.
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W7033609844
Cites: 178
Cited by:
Related to: 9